baber/WOPTO huggingface dataset:
Patent EP-2885131-A1 (EP)
Title: Registerhaltiges anordnen von druckplatten auf druckmaschinenzylindern mit temperiersystem
Inventor: SCHWITZKY VOLKMAR
IPC: B41F33/00
Filed: 2013-04-25
Abstract: Die Erfindung betrifft ein Verfahren zum registerhaltigen Anordnen zumindest zweier Druckplatten (73) auf zumindest zwei Plattenzylindern (07) einer Druckmaschine (01) zueinander, wobei in Abhängigkeit von einem auf einen Bedruckstoff (09) aufgedruckten Druckbild Einstellungen für eine Temperatur einer auf einem der Plattenzylinder angeordneten Druckplatte und/oder eines Zylinderballens (12) des Plattenzylinders und/oder eines mit dieser Druckplatte und/oder diesem zumindest einen Plattenzylinder zusammenwirkenden Temperiermittels (126; 136; 137) ermittelt werden und die eine Temperatur dieser einen Druckplatte und/ oder dieses Zylinderballens und/oder dieses Temperiermittels gemäß den Einstellungen derart verändert wird, dass sich danach ein auf der Druckplatte angeordnetes Bildformelement und ein auf einer anderen der Druckplatten angeordnetes Bildformelement zumindest bezüglich einer auf einen Plattenzylinder bezogen axialen Richtung (A) in einer vorgegebenen relativen Lage zueinander befinden und/oder wobei die Druckmaschine eine Druckeinheit aufweist, die einen Übertragungszylinder (06) aufweist, der mit mehreren Plattenzylindern in Kontakt steht sowie ein System zur Registerregelung (128).
Patent EP-2823686-A1 (EP)
Inventor: LIANG ZHENG
IPC: H04W74/08
Filed: 2013-03-04
Abstract: The invention relates to a method, in an access point of a wireless local area network, of scheduling a radio resource, wherein at least one categorization rule is set in the wireless local area network, and at least one access group is set for a plurality of non-access-point stations served by the access point according to each of the at least one categorization rule, the method comprising the steps of: sending at least one categorization message to at least one of the plurality of stations, each categorization message comprising information about one of all the access groups which are set in the wireless local area network according to the at least one categorization rule; and sending a clear-to-send frame to the plurality of stations to indicate a radio resource allocated to an access group to be protected among all the access groups. The invention can distinctly resolve the contention for radio resource between the stations, effectively limit the number of concurrently contending stations and provide flexibility in access control of an access group.
Patent EP-2844883-A1 (EP)
Inventor: WILSON JAMES
IPC: F16B43/00
Filed: 2013-04-25
Abstract: A bush assembly comprising a component (1) having a bore (3), a bush (5) fitted in the bore and having a flange (9) that extends radially outwardly over a surface of the component surrounding the bore, and a seal assembly for sealing the interface between the flange and the surface of the component, wherein the seal assembly includes a seal member and a layer of sealant (22) between the seal member and the interface between the flange and the surface of the component. Also a method for sealing a bush (5), a kit of parts for forming a bush assembly, and a clamping tool (24)for forming a bush assembly.
Patent EP-2988699-A1 (EP)
Inventor: LATHUILIERE AURÉLIEN
IPC: A61F2/02
Filed: 2013-04-24
Abstract: Provided herein is a cell encapsulation device comprising an internal chamber suitable for holding biological agents, wherein the internal chamber is disposed between a first semipermeable layer and a second semi-permeable layer, and the first and second semi-permeable layers are mounted on a supporting frame surrounding a perimeter of the internal chamber; wherein the supporting frame comprises a first frame element and a second frame element, and the first and second frame elements co-operate to position the first and second semipermeable layers at a predetermined separation distance between the layers.
Patent EP-2841221-A1 (EP)
Inventor: MALHERBE GUILLAUME
IPC: B22C9/04
Filed: 2013-04-04
Abstract: The subject of the invention is a method for obtaining a metal component from a lost form (2) placed inside a container (1). The method involves a step (A) of filling the container (1) with a filling material (3). The method comprises a step (B) of bringing a thermoset element (7) into contact with at least one free face (8) that the lost form (2) comprises.
Patent EP-2841870-A1 (EP)
Title: 3d-szenario-aufzeichnung mit waffenwirkungssimulation
Inventor: WENDT KLAUS
IPC: G09B9/00
Filed: 2013-04-26
Abstract: Die Erfindung betrifft ein Verfahren zur dreidimensionalen Szenario- Aufzeichnung von Handlungsgeschehen bei Feuergefechtsübungen in Nahbereichen, bei denen mehrere, synchronisierte bildgebende Systeme (BGS), wie Video-Kameras, Scanner o.ä. zur Überwachung der Übungsbereiche installiert werden, wobei eine Software -aus den Aufnahmen der BGS ein fotorealistisches 3D-Modell des Szenarios errechnet und das Handlungsgeschehen fortlaufend als 3D-Szenario aufzeichnet, -Personen, Waffen und andere Ausrüstungsgegenstände (z.B. Schutzkleidung) erkennt und mit ihren anatomischen, ballistischen, materialtypischen und optischen Merkmalen als Objekt-Baustein im 3D-Modell weiter verarbeitet und wiedergibt, -Position und Orientierung von Waffen und deren Abfeuern erkennt, die Fluglinie von Projektilen berechnet und im 3D-Modell abbildet, und -bei von Projektilen getroffenen Personen anhand der Trefferposition, eventuell erkannter Schutzkleidung und den ballistischen Faktoren die Waffenwirkung berechnet.
Patent EP-2838917-A1 (EP)
Inventor: DE KRUIF CORNELIS ADRIAAN
IPC: C12P21/00
Filed: 2013-04-19
Abstract: L'invention concerne des moyens et des procédés de production d'une ou de plusieurs molécules de type Ig dans une cellule hôte unique. De nouvelles mutations CH3, permettant la production de molécules d'intérêt de type Ig monospécifique et/ou bispécifique, sont également décrites.
Patent EP-2827186-A1 (EP)
Inventor: ZHENG WEIXIN
IPC: F21V8/00
Filed: 2013-03-01
Abstract: According to the present disclosure, there are provided a backlight module and a display device. With the backlight module, a heat dissipating device can be saved, and a light guide plate is prevented from being warped and deformed due to heat generation of a light source. The backlight module comprises a light source, a light guide plate and a side-glowing optical fiber. The side-glowing optical fiber includes: a light emitting section which is fixed to at least one side of the light guide plate; and a light guide section, which extends from the light emitting section to the outside of the light guide plate, and a terminal of which is connected to the light source.
Patent EP-2864514-A1 (EP)
Inventor: MUELLER HEINZ
IPC: C22F1/00
Filed: 2013-06-20
Abstract: L'invention concerne un alliage de magnésium et un procédé pour sa production et son utilisation, l'alliage de magnésium comprenant : 1,5 à 7,0% en poids de Zn, 0,5 à 3,5% en poids d'Al, le reste étant du magnésium contenant des impuretés, qui favorisent des différences de potentiel électrochimique et/ou la formation de précipitations et/ou phases intermétalliques, en une quantité totale de pas plus de 0,0063% en poids de Fe, Si, Mn, Co, Ni, Cu, Zr, Y, Sc ou des terres rares présentant les nombres ordinaux 21, 57 à 71 et 89 à 103, Be, Cd, In, Sn et/ou Pb ainsi que P.
Patent EP-2867243-A1 (EP)
Inventor: SKOWERSKI KRZYSZTOF
IPC: C07C7/12
Filed: 2013-06-14
Abstract: La présente invention concerne des complexes métalliques inédits, par exemple des composés de formule 1, et leur application dans le cadre de la métathèse des oléfines ou des alcynes, ainsi que des procédés de mise en œuvre de réactions de métathèse des oléfines.
Patent EP-2870460-A1 (EP)
Inventor: PILTOFT JENS SPANGGAARD
IPC: G01N21/552
Filed: 2013-07-01
Abstract: L'invention concerne un système complémentaire destiné à un spectromètre infrarouge à réflectance totale atténuée (ATR-IR), ledit système complémentaire permettant d'effectuer des mesures IR in situ à résolution temporelle de mélanges hétérogènes. Le dispositif complémentaire comprend un microréacteur (300A) formant une cavité d'échantillon (305) quand le microréacteur (300A) est placé du côté surface d'échantillon d'une plaque d'ATR-IR (200), un aimant d'échantillon (312) conçu pour être placé dans la cavité d'échantillon (305), et un système d'aimants (400) comprenant un aimant extérieur (402), ledit système d'aimants (400) étant conçu pour faire tourner l'aimant extérieur (402) dans un plan sensiblement parallèle au plan dans lequel la plaque d'ATR-IR (200) se situe. Quand le microréacteur (300A) est placé sur la plaque d'ATR-IR (200), l'aimant extérieur (402) est conçu pour faire tourner l'aimant d'échantillon (312) à l'intérieur de la cavité d'échantillon (305).
Patent EP-2805858-A1 (EP)
Inventor: KODAKA KATSUAKI
IPC: B60T7/08
Filed: 2013-01-18
Abstract: A hydraulic control device for work machine includes: a driving device that generates a driving force for traveling of the work machine; a park braking device that parks the work machine; an operating unit that is provided in a cab of the work machine and operated by an operator for driving a work device; a hydraulic brake device that generates a braking force according to operation of a brake pedal; a hydraulic lock unit that hydraulically locks the hydraulic brake device to cause the hydraulic brake device to be continuously operated; a work device drivable state judging unit that judges whether or not the work device is in a work device drivable state in which the work device can be driven; and a park brake control unit that brings the park braking device into operation when the hydraulic lock unit hydraulically locks the hydraulic brake device and the work device drivable state judging unit judges that the work device drivable state has not been established.
Patent EP-2875528-A1 (EP)
Inventor: GUERRINI NICOLA
IPC: H04N5/3745
Filed: 2013-07-17
Abstract: An imaging sensor device has an array of pixel sensors in rows and columns. The array comprises: a plurality of stitching blocks, each comprising a plurality of pixel sensors disposed in at least one row group; and first and second groups of addressing lines, the arrangement of pixel sensors and addressing lines in each stitching block being the same. Row addressing circuitry is disposed along an external edge of the array parallel to the rows of pixel sensors, coupled to the pixel sensors using the first group of addressing lines for performing a row addressing action and group addressing circuitry is disposed along the same edge of the array, coupled to the pixel sensors using at least some of the second group of addressing lines for performing a group addressing action. Each stitching block combines a row addressing action with a group addressing action to select only one row of one row group of one stitching block simultaneously.
Patent EP-2810655-A1 (EP)
Inventor: ISHII MASARU
IPC: A61K45/00
Filed: 2013-01-28
Abstract: The present invention provides a novel antitumor agent that acts through a novel mechanism. The novel antitumor agent contains as an active ingredient a substance capable of inhibiting a cell cycle-dependent Rho GTPase activating protein (RhoGAP). The RhoGAP is cell cycle-dependent and plays an important role in a process through which cancer cells acquire invasive capacity and/or metastatic capacity. The invasion and/or metastasis of cancer cells can be controlled by targeting the RhoGAP. Examples of the substance capable of inhibiting a cell cycle-dependent RhoGAP include an antisense oligonucleotide against a gene encoding the RhoGAP and an oligonucleotide that induces RNA interference of the gene. As the oligonucleotide, one containing an artificial nucleic acid such as BNA is preferred because of its excellent stability. The present invention also provides a screening method including selecting an antitumor agent capable of suppressing cancer cell invasion and/or metastasis through a novel mechanism. The screening method is a screening method for a novel antitumor agent, including selecting a substance capable of inhibiting a cell cycle-dependent Rho GTPase activating protein.
Patent EP-2808517-A1 (EP)
Title: Six-cycle engine having scavenging stroke
Inventor: TSUKAHARA EI
IPC: F02M25/07
Filed: 2013-01-16
Abstract: A six-stroke cycle engine comprising: an intake passage (10) having a downstream end connected to a combustion chamber (6) and including no throttle valve provided therein; and an exhaust passage (15) having an upstream end connected to the combustion chamber (6) and including a catalyst (16) provided in the midway. The six-stroke cycle engine includes a first valve configured to open/close the intake passage (10), and a second valve (4) configured to open/close the exhaust passage (15). The six-stroke cycle engine includes a valve gear (8) configured to operate the first valve and the second valve so that an intake stroke, a compression stroke, an expansion stroke, and an exhaust stroke are executed in the order named, and to operate only the first valve so that a scavenging intake stroke and a scavenging exhaust stroke are executed in the order named next to the exhaust stroke. The valve gear (8) includes a variable valve mechanism (9) capable of continuously changing an opening/closing timing and a lift amount of the first valve. The variable valve mechanism (9) controls an intake air volume in the intake stroke. Pumping loss can be reduced while preventing fresh air from being discharged to the exhaust passage (15) in the scavenging exhaust stroke.
Patent EP-2811019-A1 (EP)
Inventor: MATSUNO TATSUKI
IPC: C12N15/09
Filed: 2013-01-23
Abstract: The present invention provides a method for stably correcting a detection signal in an isothermal nucleic acid amplification reaction, particularly an isothermal nucleic acid amplification reaction performed at low temperature. 
     Specifically, the present invention provides a method for detecting a target nucleic acid in an isothermal nucleic acid amplification reaction, comprising the following (1) and (2): 
(1) subjecting a nucleic acid sample to an amplification reaction of a target nucleic acid under an isothermal condition in the presence of a nucleic acid probe for correction and a nucleic acid probe for detection of the target nucleic acid; and 
(2) correcting a detection signal due to the nucleic acid probe for detection with a detection signal due to the nucleic acid probe for correction in the amplification reaction.
Patent EP-2856156-A1 (EP)
Inventor: GJELSTAD ASTRID
IPC: A61B5/15
Filed: 2013-05-29
Abstract: Provided herein is technology relating to the collection of biological samples and particularly, but not exclusively, to compositions, methods, and uses related to using a biopolymer substrate to collect biological samples for analysis.
Patent EP-2886816-A1 (EP)
Inventor: KANAMORI SHIROU
IPC: F01N13/18
Filed: 2013-03-26
Abstract: A wheel loader (1) comprises an engine (18), a selective catalyst reduction device (23), a cab (7), a ladder (12), a urea aqueous solution tank (13), and an injection device (24). The selective catalyst reduction device (23) treats exhaust gas from the engine (18). The ladder (12) is provided on the right side of the cab (7) and is used for ascending to and descending from the cab (7). The urea aqueous solution tank (13) is disposed behind the ladder (12) and stores a urea aqueous solution. The injection device (24) injects the urea aqueous solution into the exhaust gas fed from the engine (18) toward the selective catalyst reduction device (23).
Patent EP-2817051-A1 (EP)
Inventor: TUCKER CHRISTOPHER S
IPC: A24F40/48
Filed: 2013-02-22
Abstract: An electronic cigarette includes a capillary tube in communication with a liquid supply including liquid material and a heater operable to heat the capillary tube to a temperature sufficient to vaporize the liquid material contained therein and form an aerosol. The liquid supply is adapted to be squeezed or otherwise compressed so as to allow a smoker to manually pump liquid to the capillary tube and simultaneously activate the heater.
Patent EP-2885279-A1 (EP)
Inventor: WINTERS MICHAEL P
IPC: A61P29/00
Filed: 2013-08-16
Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, Q, and G are defined herein.
Patent EP-2891318-A1 (EP)
Inventor: MOUNTANOS PETE
IPC: H04N21/454
Filed: 2013-08-19
Abstract: Example apparatus and methods concern selectively accepting or rejecting content based on ratings identifier information included in the content. Example apparatus and methods facilitate identifying a content fragment (e.g., f-MP4 fragment) to be rejected based on an identifier located in the fragment rather than information located in some external source (e.g., Event Information Table (EIT)). One example method includes identifying a fragment based on a ratings identifier encoded as a universally unique identifier (UUID) in the fragment and then selectively accepting or rejecting the fragment based on the rating. Rather than rely only on a predicted start time, a predicted end time, a predicted source, and a pre-determined coarse-grained rating, example apparatus and methods may be better prepared to account for unanticipated start times, ending times, schedule changes, and source changes, and may provide finer grained user control based on ratings carried in content.
Patent EP-2892869-A1 (EP)
Title: Verfahren zur herstellung von menthon aus isopulegol
Inventor: SCHAUB THOMAS
IPC: C07C45/51
Filed: 2013-08-28
Abstract: Die vorliegende Erfindung betrifft ein Verfahren zur Darstellung von Menthon ausgehend von Isopulegol unter Verwendung spezieller homogener Katalysatoren.
Patent EP-2822931-A1 (EP)
Inventor: STOCK NICHOLAS SIMON
IPC: C07D417/10
Filed: 2013-03-07
Abstract: The invention disclosed herein is directed to compounds of Formula (I) and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula (I), or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist. The compounds and pharmaceutical compositions of the invention are also useful in the treatment of viral infections, such as HCV infections and HIV infections. The invention disclosed herein is also directed to a methods of preventing the onset of and/or recurrence of acute and chronic myeloid leukemia, as well as other cancers, comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist.
Patent EP-2903591-A1 (EP)
Inventor: GAVARD MOLLIARD SAMUEL
IPC: A61K6/838
Filed: 2013-09-24
Abstract: La présente invention a pour objet une formulation aqueuse stérile injectable résorbable, prête à l'emploi, utilisée dans des buts thérapeutiques sous forme de gel viscoélastique cohésif particulaire comprenant i) de l'acide hyaluronique réticulé, ou l'un de ses sels, à une concentration comprise entre 1% à 4% (masse/volume); la réticulation effectuée permettant d'obtenir un gel à base d'acide hyaluronique réticulé de structure dite cohésive, et ii) de l'hydroxyapatite, à une concentration comprise entre 10% à 70% (masse/volume), ladite hydroxyapatite étant sous forme de particules de taille moyenne inférieure ou égale à 650 μm; ladite formulation aqueuse stérile 10 injectable possédant des propriétés viscoélastiques telles que Tanδ à la fréquence de 1 Hz est inférieur ou égal à 0.60.
Patent EP-2911949-A1 (EP)
Title: Behälter und verfahren zur zugabe einer mischkomponente
Inventor: KRAMMER CHRISTIAN
IPC: B65D51/28
Filed: 2013-10-17
Abstract: Die Erfindung betrifft einen Behälter (11) und dessen Verwendung. Der Behälter weist eine Kammer (21) mit einem Boden (23) zur Aufnahme einer Mischkomponente und einen. Adapter (51) zur Befestigung der Kammer (21) an einem zweiten Behälter (13) auf. Der Adapter (51) ist über ein erstes Verbindungsmittel (61) mit der Kammer (21) verbunden und weist ein zweites Verbindungsmittel (63) zur Verbindung mit dem zweiten Behälter (13) auf. Zudem bildet er einen sich zwischen dem ersten und dem zweiten Verbindungsmittel (61) und (63) erstreckenden Durchflusskanal (65) für die Mischkomponente. Zudem weist der Adapter (51) im Durchflusskanal (65) ein Schneidelement (71) mit einer dem Boden (23) der Kammer (21) zugewandten Schneide (73) zum Öffnen des Bodens (23) auf. Das erste Verbindungsmittel (61) ermöglicht eine Drehung der Kammer (21) relativ zum Adapter (51) und zur Schneide (73), wobei die Schneide (73) dazu ausgebildet ist, bei Drehung der Kammer (21) den Boden (23) der Kammer (21) entlang seines Randes zu durchtrennen und wobei die Kammer (21) und der Adapter (51) miteinander unlösbar verbunden sind.
Patent EP-3065592-A1 (EP)
Inventor: HERNÁNDEZ SEGURA CARMEN
IPC: A46B11/00
Filed: 2013-11-08
Abstract: It comprises a sleeve (110) having an interior (120) for receiving at least one finger (130) of the user through at least one opening (140). The sleeve (110) comprises an inner portion(150), an applicator portion (160) at least part of which is suitable for applying a product, and a removable protective film (170) for at least partially covering the applicator portion (160). The removable protective film (170) may have at least one protective extension (180) to be pulled for removal. At least one end of the sleeve (110) may extend to at least one sleeve extension (190).
Patent EP-2849760-A1 (EP)
Inventor: BAZINET MICHEL
IPC: A61P25/28
Filed: 2013-05-17
Abstract: L'invention concerne des compositions pharmaceutiques et des procédés de traitement d'infections virales, d'hypercholestérolémie, d'hypertriglycéridémie, de maladie d'Alzheimer, de maladies à prions, de la dystrophie musculaire de Duchenne au moyen de complexes chélatés oligonucléotidiques.
Patent EP-2879426-A1 (EP)
Inventor: SUN AIFANG
IPC: H04W48/14
Filed: 2013-06-24
Abstract: A method for service content distribution under a heterogeneous network and a service management platform are provided. The method includes that the service management platform stores and maintains the context information of a network and a terminal, and the service management platform makes a query to obtain an index of the context information according to a received service request, selects a cooperative network and terminal for service content distribution, and performs service content distribution according to the selected cooperative network and terminal. Accordingly, a proper network and a proper terminal can be selected according to a service request under a heterogeneous network, terminals in a surrounding environment of a user are fully utilized, and radio resources are further fully utilized.
Patent EP-2858399-A1 (EP)
Inventor: TAKANO HIROAKI
IPC: H04W72/04
Filed: 2013-03-14
Abstract: There is provided a communication control apparatus including a radio communication unit configured to wirelessly communicate with a terminal apparatus to which a first operator provides a radio communication service, the terminal apparatus being capable of radio communication by using one primary frequency band and at least one secondary frequency band, and a control unit configured to control access of the terminal apparatus in a manner that a frequency band among one or more frequency bands owned by a second operator is not used as the one primary frequency band of the terminal apparatus, the frequency band being temporarily used by the first operator.